Wells Fargo analyst Stan Berenshteyn raised the firm’s price target on Doximity (DOCS) to $43 from $41 as estimates positioned for potential near-term upside. But upside to price target likely demands growth cadence that appears out of reach, Wells says, keeping the firm on the sidelines with an Equal Weight rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCS: